Paolo Pucci
Directeur/Membre du Conseil chez WEST PHARMACEUTICAL SERVICES, INC.
Fortune : 4 M $ au 30/04/2024
Relations actives
| Nom | Sexe | Age | Sociétés liées | Collaboration |
|---|---|---|---|---|
| Philip Astley-Sparke | M | 51 | 9 ans | |
| Bill Lundberg | M | 60 | 5 ans | |
| Robert Coffin | M | 58 | 9 ans | |
| Kapil Dhingra | M | 64 | 12 ans | |
| Peter Silverman | M | 46 | 7 ans | |
| Sushil Patel | M | 52 | 3 ans | |
| Bernard Birkett | M | 55 | 6 ans | |
| Eric Green | M | 55 | 9 ans | |
| Gregory Perry | M | 63 | 8 ans | |
| Mark Iwicki | M | 57 | 9 ans | |
| Sushant Kumar | M | - |
Tarus Therapeutics, Inc.
 Tarus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Part of Portage Biotech, Inc., Tarus Therapeutics, Inc. is a company developing small molecule inhibitors of adenosine receptors for cancer immunotherapy and select non-oncology indications. The company is based in New York, NY. The company has a comprehensive portfolio of adenosine receptor antagonists in development, including both first-in-class and programs. The company was founded by Sushant Kumar and Peter R. Molloy, with Sushant Kumar serving as CEO since incorporation. Tarus Therapeutics was acquired by Portage Biotech, Inc. on July 05, 2022 for $49.20 million. | - |
| Dieter Weinand | M | 63 | 6 ans | |
| Anand Mehra | M | 48 | 9 ans | |
| Christy Oliger | F | 54 | 3 ans | |
| Robert Glassman | M | 62 |
Tarus Therapeutics, Inc.
Tarus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Part of Portage Biotech, Inc., Tarus Therapeutics, Inc. is a company developing small molecule inhibitors of adenosine receptors for cancer immunotherapy and select non-oncology indications. The company is based in New York, NY. The company has a comprehensive portfolio of adenosine receptor antagonists in development, including both first-in-class and programs. The company was founded by Sushant Kumar and Peter R. Molloy, with Sushant Kumar serving as CEO since incorporation. Tarus Therapeutics was acquired by Portage Biotech, Inc. on July 05, 2022 for $49.20 million. | 3 ans |
| Andrew Schwendenman | M | 47 | 4 ans | |
| Silji Abraham | M | 52 | 6 ans | |
| Kimberly MacKay | F | 58 | 4 ans | |
| Victor Sandor | M | 57 | 5 ans | |
| Len Kanavy | M | 62 | 6 ans | |
| Cindy Reiss-Clark | F | 50 | - | |
| Sherri L. Spear | F | - | - | |
| Andrew Muratore | M | - | 3 ans | |
| Deborah Baron | F | 55 | 3 ans | |
| Deborah Keller | F | 61 | 7 ans | |
| Molly Joseph | F | 50 | 3 ans | |
| David Epstein | M | 62 |
Tarus Therapeutics, Inc.
Tarus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Part of Portage Biotech, Inc., Tarus Therapeutics, Inc. is a company developing small molecule inhibitors of adenosine receptors for cancer immunotherapy and select non-oncology indications. The company is based in New York, NY. The company has a comprehensive portfolio of adenosine receptor antagonists in development, including both first-in-class and programs. The company was founded by Sushant Kumar and Peter R. Molloy, with Sushant Kumar serving as CEO since incorporation. Tarus Therapeutics was acquired by Portage Biotech, Inc. on July 05, 2022 for $49.20 million. | 4 ans |
| Colin Love | M | 65 | 9 ans | |
| Douglas Michels | M | 66 | 13 ans | |
| William Feehery | M | 54 | 12 ans | |
| Robert Friel | M | 68 | 4 ans | |
| Thomas Hofmann | M | 72 | 17 ans | |
| Joseph Slattery | M | 59 | 7 ans | |
| Mark Buthman | M | 63 | 13 ans | |
| Myla Lai-Goldman | M | 66 | 10 ans | |
| Veleka Peeples-Dyer | F | 52 | 1 ans | |
| Peter Molloy | M | 52 |
Tarus Therapeutics, Inc.
Tarus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Part of Portage Biotech, Inc., Tarus Therapeutics, Inc. is a company developing small molecule inhibitors of adenosine receptors for cancer immunotherapy and select non-oncology indications. The company is based in New York, NY. The company has a comprehensive portfolio of adenosine receptor antagonists in development, including both first-in-class and programs. The company was founded by Sushant Kumar and Peter R. Molloy, with Sushant Kumar serving as CEO since incorporation. Tarus Therapeutics was acquired by Portage Biotech, Inc. on July 05, 2022 for $49.20 million. | - |
| Stephen Lockhart | M | 65 | 2 ans | |
| Hyam Levitsky | M | 66 | 6 ans | |
| Cecilia Anna Wilhelmina Geuijen | M | 56 | 3 ans | |
| Christopher Sarchi | M | 55 | 1 ans | |
| Konstantinos Xynos | M | 57 | 2 ans | |
| Michele Polinsky | M | - | - | |
| Robert Segura | M | - | 3 ans | |
| Donald A. McMillan | M | 65 | 27 ans | |
| Ernesto Wasserman | M | - | 8 ans | |
| Ashley Pereira | M | - | 3 ans | |
| Shannon Campbell | F | - | 2 ans | |
| Chris Ryan | M | - | - | |
| Alexander Berthold Hendrik Bakker | M | 57 | 14 ans | |
| Kathleen Farren | F | - | - | |
| Paul Achleitner | M | 67 | 22 ans | |
| Andrew Joe | M | 58 | 4 ans | |
| Harry Shuman | M | - | - | |
| Maxine Gowen | M | 66 | 3 ans | |
| Emily Hill | F | 44 | 1 ans | |
| Liu Hui | M | 51 | 9 ans | |
| Arleen Goldenberg | F | - | - | |
| Chad Winters | M | 45 | 5 ans | |
| Quintin Lai | M | 57 | 8 ans | |
| Annette Favorite | F | 59 | 9 ans | |
| C. Nicholson | M | 68 |
Tarus Therapeutics, Inc.
Tarus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Part of Portage Biotech, Inc., Tarus Therapeutics, Inc. is a company developing small molecule inhibitors of adenosine receptors for cancer immunotherapy and select non-oncology indications. The company is based in New York, NY. The company has a comprehensive portfolio of adenosine receptor antagonists in development, including both first-in-class and programs. The company was founded by Sushant Kumar and Peter R. Molloy, with Sushant Kumar serving as CEO since incorporation. Tarus Therapeutics was acquired by Portage Biotech, Inc. on July 05, 2022 for $49.20 million. | 4 ans |
| John de Kruif | M | 60 | 17 ans |
Graphique Relationnel
Relation dans plusieurs entreprises
Anciennes relations
| Nom | Sexe | Age | Sociétés liées | Collaboration |
|---|---|---|---|---|
| George Migausky | M | 69 | 8 ans | |
| Andrew Ashe | M | 57 | 13 ans | |
| Jean Franchi | F | 57 | 4 ans | |
| Gustav Christensen | M | 76 | 9 ans | |
| Robert A. Uger | M | 53 | 8 ans | |
| Robert L. Kirkman | M | 75 | 8 ans | |
| James Parsons | M | 58 | 10 ans | |
| David J. McLachlan | M | 86 | 17 ans | |
| Henry E. Blair | M | 80 | 27 ans | |
| Jan Skvarka | M | 57 | 2 ans | |
| Ivana Magovcevic-Liebisch | M | 55 | 12 ans | |
| Patrick Zenner | M | 77 | 20 ans | |
| Ulrich Hauck | M | 60 | 12 ans | |
| Penka Petrova | M | 56 | 8 ans | |
| Thomas Hoffmann | M | 53 | 5 ans | |
| Joseph Saluri | M | 57 | 7 ans | |
| Willy Beumann | M | 68 | - | |
| Johannes M. Dietsch | M | 62 | 16 ans | |
| Bernd Metzner | M | 53 | 4 ans | |
| Paul Walker | M | 49 | 1 ans | |
| Frank Morich | M | 69 | 20 ans | |
| Thomas Lenox Kempner | M | 96 | 21 ans | |
| Hugo Slootweg | M | 53 | 8 ans | |
| Klaus Sturany | M | 77 | - | |
| Paula Johnson | M | 64 | 16 ans | |
| Paul Edick | M | 67 | 7 ans | |
| Helmut Gunter Wilhelm Panke | M | 77 | - | |
| Michael A. Anderson | M | 68 | 24 ans | |
| David Montecalvo | M | 58 | 6 ans | |
| Henry Lewis | M | 98 | 17 ans | |
| John Weiland | M | 68 | 12 ans | |
| Klaus-Christian Kleinfeld | M | 65 | 9 ans | |
| Mary Gray | M | 71 | 12 ans | |
| William Federici | M | 64 | 15 ans | |
| Chad Johnson | M | 45 | - |
Statistiques
| Pays | Relations | % du total |
|---|---|---|
| Etats-Unis | 34 | 34,69% |
| Suisse | 27 | 27,55% |
| Pays-Bas | 19 | 19,39% |
| Allemagne | 10 | 10,20% |
| Canada | 8 | 8,16% |
Age des relations
Actives
Passées
Homme
Femme
Administrateurs
Exécutifs
Provenance des relations
- Bourse
- Insiders
- Paolo Pucci
- Réseau Personnel
